poisar

Stocks · News reference

Chip Selloff Drags Nasdaq 100, Gold Sinks Below $4,000: Stock Market Today

Piero Cingari

A semiconductor selloff sank the Nasdaq 100 more than 1% while UnitedHealth's blowout quarter lifted the Dow.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ABTASTSBECTASDIAGLDIWMJBHTPLQQQRHIRKLBSMGSNDKSPYTSMUNHVOOXLKXLPXLV
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Sns Insider

    Baby Food & Infant Formula Market Size to Reach USD 74.30 Billion by 2035 | Report by SNS Insider

    The global Baby Food and Infant Formula Market was valued at USD 40.37 billion in 2025 and is projected to reach USD 74.30 billion by 2035, growing at a CAGR of 6.29%. Growth is driven by urbanization, increasing parental health consciousness, demand for organic/premium products, and e-commerce expansion. However, recent product recalls by major manufacturers highlight safety concerns in the industry.

    ABTNSRGYDANOYKHC
  2. Researchandmarkets.Com

    Renal Denervation Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)

    The global renal denervation market is expected to experience significant growth driven by rising resistant hypertension cases, positive clinical trial results, regulatory approvals, and technological advances in radiofrequency, ultrasound, and micro-infusion technologies. North America currently leads the market while Asia-Pacific is projected to grow fastest. The minimally invasive procedure treats uncontrolled hypertension by disrupting sympathetic nerves surrounding renal arteries.

    MDTBSXJNJABT
  3. Leo Sun

    If the AI Boom Slows Down, History Says This Is the Smartest Way to Protect Your Long-Term Portfolio

    As concerns grow about a potential AI market slowdown due to inflation, rate hikes, and geopolitical tensions, investors should consider diversifying into dividend-focused ETFs like SCHD. The Schwab U.S. Dividend Equity ETF offers exposure to 100 stable, dividend-paying stocks across multiple sectors, providing a defensive hedge against AI stock volatility while delivering steady income and historical returns of 243% over the past decade.

    SCHDNVDAAVGOAMZNMRK
  4. Brendan Coffey

    AST SpaceMobile vs. Space Exploration Technologies: Which Telecom Stock Is a Better Buy in 2026?

    AST SpaceMobile and SpaceX compete in satellite connectivity but with different business models. AST SpaceMobile focuses on direct-to-device smartphone connectivity with partnerships from major telecom operators, while SpaceX leverages reusable rockets to scale its Starlink broadband service. Despite SpaceX's larger revenue base ($18.7B vs $70.9M) and established business, the article recommends AST SpaceMobile for 2026 due to strong telecom backing and clearer near-term profitability path, though both companies face significant cash burn and execution risks.

    ASTSSPCXTTBBTPA
  5. Micah Zimmerman

    All Eyes Are on SpaceX's Next Share Unlock on Sept. 9. But These 3 Unstoppable Growth Stocks Are Better Buys Hiding in Plain Sight.

    SpaceX faces a potential technical headwind on Sept. 9 when 319 million shares become eligible for sale from early stakeholders. Rather than SpaceX, the article highlights three alternative space infrastructure companies with stronger growth potential: Rocket Lab (developing reusable medium-lift rockets), AST SpaceMobile (building satellite-based cellular networks), and Redwire (providing spacecraft power and manufacturing systems).

    SPCXRKLBASTSRDW
  6. Leo Sun

    AST Spacemobile Just Moved Its Commercial Launch Target to 2027. Is That Bad News for Its Stock?

    AST SpaceMobile pushed back its target of deploying 45 satellites from late 2026 to early 2027, disappointing investors and contributing to a stock decline from a record high of $133.09 to the low $60s. Despite the delay caused by the loss of BlueBird 7 in April, the company maintains strong fundamentals including partnerships with 60+ carriers, a $1.3 billion backlog, and analyst projections showing revenue growth from $71 million in 2025 to $1.73 billion by 2028.

    ASTSTTBBTPATPC